| Literature DB >> 19742177 |
Bruno Pagano1, Carlo Andrea Mattia1, Concetta Giancola2.
Abstract
G-quadruplexes are higher-order nucleic acids structures formed by G-rich sequences that are stabilized by tetrads of hydrogen-bonded guanine bases. Recently, there has been growing interest in the study of G-quadruplexes because of their possible involvement in many biological processes. Isothermal titration calorimetry (ITC) has been proven to be a useful tool to study the energetic aspects of G-quadruplex interactions. Particularly, ITC has been applied many times to determine the thermodynamic properties of drug-quadruplex interactions to screening among various drugs and to address drug design. In the present review, we will focus on the ITC studies of G-quadruplex structures and their interaction with proteins and drugs and the most significant results will be discussed.Entities:
Keywords: G-quadruplex; drug; isothermal titration calorimetry; thermodynamic
Mesh:
Year: 2009 PMID: 19742177 PMCID: PMC2738904 DOI: 10.3390/ijms10072935
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1.(a) NMR structure of the anti-parallel G-quadruplex formed by the d[AG3(T2AG3)3] sequence in Na+ solution (pdb code: 143D). (b) Crystal structure of the parallel G-quadruplex formed by the d[AG3(T2AG3)3] sequence in the presence of K+ (pdb code:1KF1). (c) NMR structure of the G-quadruplex formed by the d[TAG3(T2AG3)3] sequence (hybrid-1) in K+ solution (pdb code: 2JSM). (d) NMR structure of the G-quadruplex formed by the d[TAG3(T2AG3)3TT] sequence (hybrid -2) in K+ solution (pdb code: 2JSL). (e) NMR structure of the antiparallel G-quadruplex formed by the d[G3(T2AG3)3T] sequence in K+ solution (pdb code: 2KF8). (f) NMR structure of the thrombin binding aptamer (TBA) (pdb code: 1RDE).
Figure 2.Chemical structures of quadruplex-interactive compounds studied by ITC.
Thermodynamic parameters for ligands binding to G-quadruplex structures obtained by ITC at 25 °C.
| Δ | ||||||||
|---|---|---|---|---|---|---|---|---|
| TMPyP4 | d(G2T2G2TGTG2T2G2) | K+ | 1 | 17.8 × 104 | −40.2 | −30.1 | −10.0 | [ |
| TMPyP4 | d[AG3(T2AG3)3] | K+ | 1.9 | 2.8 × 104 | −17.6 | −25.5 | 8.0 | [ |
| TMPyP4-1 | d[AG3(T2AG3)3] | Na+ | 1.1 | 3.3 × 104 | −28.4 | −25.9 | −2.5 | [ |
| TMPyP4-2 | d[AG3(T2AG3)3] | Na+ | 1.0 | ~0.2 × 104 | ~−25 | n.d. | n.d. | [ |
| TMPyP4 | [d(T4G4)]4 | K+ | 2.9 | 7.7 × 104 | −38.1 | −28.0 | −10.0 | [ |
| TMPyP4-1 | [d(T4G4)]4 | Na+ | 1.1 | 162 × 104 | −28.0 | −35.6 | 7.5 | [ |
| TMPyP4-2 | [d(T4G4)]4 | Na+ | 2.0 | 4.4 × 104 | −105.8 | −26.3 | −79.5 | [ |
| TMPyP4 | [d(AG3T)]4 | Na+ | 0.5 | 1.7 × 105 | −40.5 | −30.0 | 6.9 | [ |
| TMPyP4 | [d(TG4T)]4 | Na+ | 2 | 2.5 × 105 | −23.9 | −30.8 | −10.6 | [ |
| TMPyP4-1 | d[G3(T2AG3)3] | K+ | 1 | 4.0 × 106 | −7.9 | −37.6 | 29.7 | [ |
| TMPyP4-2 | d[G3(T2AG3)3] | K+ | 2 | 0.5 × 106 | −17.6 | −32.6 | 15.0 | [ |
| TMPyP4-1 | d(G4AG3TG4AG3TG4) | K+ | 1 | 7.0 × 107 | −31.4 | −44.3 | 12.9 | [ |
| TMPyP4-2 | d(G4AG3TG4AG3TG4) | K+ | 2 | 1.0 × 106 | −42.7 | −34.3 | −8.4 | [ |
| TMPyP4-1 | d(G3AG3CGCTG3AG2AG3) | K+ | 1 | 1.5 × 107 | −12.6 | −41.0 | 28.4 | [ |
| TMPyP4-2 | d(G3AG3CGCTG3AG2AG3) | K+ | 2 | 1.0 × 106 | −33.1 | −34.3 | 1.2 | [ |
| Distamycin-1 | [d(TG4T)]4 | K+ | 1.8 | 0.4 × 106 | −8.0 | −32 | 24 | [ |
| Distamycin-2 | [d(TG4T)]4 | K+ | 4.2 | 4.0 × 106 | −10.0 | −37 | 27 | [ |
| Distamycin | [d(TG4T)]4 | Na+ | 1.0 | 0.2 × 106 | −14.0 | −30 | 16 | [ |
| Distamycin | d[AG3(T2AG3)3] | K+ | 0.9 | 0.6 × 106 | −14.0 | −33 | 19 | [ |
| Distamycin | d[AG3(T2AG3)3] | Na+ | 1.0 | 1.0 × 106 | −9.0 | −34 | 25 | [ |
| [d(TG4T)]4 | K+ | 1.9 | 2.0 × 106 | 7.0 | −36 | 43 | [ | |
| [d(TG4T)]4 | Na+ | 0.9 | 2.3 × 106 | 10.0 | −36 | 46 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.0 | 2.0 × 106 | 9.0 | −36 | 45 | [ | |
| d[AG3(T2AG3)3] | Na+ | 0.9 | 6.0 × 106 | −18 | −39 | 21 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.2 | 7.9 × 104 | −23.0 | −28.0 | 5.0 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.3 | 5.1 × 104 | −42.3 | −26.8 | −15.5 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.1 | 9.7 × 104 | −60.8 | −28.5 | −32.3 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.1 | 1.4 × 104 | −20.9 | −23.7 | 2.8 | [ | |
| d[AG3(T2AG3)3] | K+ | 1.2 | 1.4 × 104 | −17.6 | −23.7 | 6.1 | [ | |
| d[AG3(T2AG3)3] | K+ | 1 | 0.5 × 104 | −6.9 | −21.1 | 14.2 | [ | |
| BRACO-19 | d[AG3(T2AG3)3] | K+ | 2 | n.d. | −34.7 | −42.3 | 7.5 | [ |
| HXDV | d[T2G3(T2AG3)3A] | K+ | 2.2 | 3.0 × 105 | −7.1 | −31.4 | 24.3 | [ |
| HXLV-AC | d[T2G3(T2AG3)3A] | K+ | 1.9 | 5.5 × 105 | −8.8 | −32.6 | 23.8 | [ |
| Berberine | d[AG3(T2AG3)3] | K+ | 1 | 0.4 × 106 | −7.1 | −32.2 | 25.1 | [ |
| Actinomycin D | d[AG3(T2AG3)3] | K+ | 0.6 | 2.3 × 105 | −28.0 | −30.6 | 2.6 | [ |
| Actinomycin D | d[AG3(T2AG3)3] | Na+ | 0.5 | 2.1 × 105 | −30.5 | −30.2 | −0.3 | [ |
These values were obtained from SPR equilibrium constant. n.d. = not determined.
Figure 3.Chemical structures of quadruplex-interactive compounds studied by ITC.